{Reference Type}: Journal Article
{Title}: CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a bioinformatics study.
{Author}: Li AH;Chen YQ;Chen YQ;Song Y;Li D;Li AH;Chen YQ;Chen YQ;Song Y;Li D;Li AH;Chen YQ;Chen YQ;Song Y;Li D;
{Journal}: J Int Med Res
{Volume}: 50
{Issue}: 8
{Year}: Aug 2022
{Factor}: 1.573
{DOI}: 10.1177/03000605221117138
{Abstract}: <B>OBJECTIVE: </B>The cell cycle-related proteins cyclin B1 (CCNB1) and cyclin B2 (CCNB2) are potentially involved in the underlying mechanisms of psoriasis. The present study aimed to explore this possibility using bioinformatics approaches.<BR><B>METHODS: </B>CCNB1 and CCNB2 protein levels were evaluated in 14 psoriasis patients and five healthy controls by enzyme-linked immunosorbent assays, and their mRNA levels were evaluated using data from four publicly available datasets (GSE53552, GSE41664, GSE14905, and GSE13355). Comparison of high- and low-expressing groups were performed to reveal CCNB1- and CCNB2-related differentially expressed genes, which were then assessed based on gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Correlation analyses between CCNB1 and CCNB2 levels and immune infiltration, as well as typical targets of psoriasis, were also performed.<BR><B>RESULTS: </B>Overall, 12 CCNB1 and CCNB2 common immune-related targets potentially involved in psoriasis were identified. These could regulate the cell cycle of through multiple pathways. In addition, CCNB1 and CCNB2 were found to potentially support the release of key molecular targets of psoriasis through the regulation of mast cell activation and macrophage polarization.<BR><B>CONCLUSIONS: </B>These findings suggest that CCNB1 and CCNB2 may represent valuable molecular biomarkers of psoriasis, contributing to its onset and progression.